首页> 外文OA文献 >DCIS II trial: a randomised trial testing observation (no radiotherapy) against radiotherapy in women with low-risk completely excised oestrogen receptor (ER) positive ductal carcinoma in situ (DCIS) of the breast on adjuvant endocrine therapy.

【2h】

DCIS II trial: a randomised trial testing observation (no radiotherapy) against radiotherapy in women with low-risk completely excised oestrogen receptor (ER) positive ductal carcinoma in situ (DCIS) of the breast on adjuvant endocrine therapy.

机译：DCIs II试验：对患有低风险完全切除的雌激素受体（ER）阳性导管原位癌（DCIs）的妇女进行辅助内分泌治疗的放射治疗的随机试验观察（无放射治疗）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yarnold, J.; Bundred, N.; Dewar, J.; George, W.; Haviland, J.S.; Dawson, C.; Bliss, J.;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献

1. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial [J] . Forbes John F., Sestak Ivana, Howell Anthony, The Lancet . 2016,第10021期

机译：Anstrozole与Tamoxifen在绝经后患者中预防局部切除的导管癌原位（Ibis-II DCIS）：双盲，随机对照试验
2. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial [J] . Forbes John F., Sestak Ivana, Howell Anthony, The Lancet . 2016,第10021期

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲，随机对照试验
3. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial [J] . Forbes John F., Sestak Ivana, Howell Anthony, The Lancet . 2016,第10021期

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲，随机对照试验
4. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind randomised controlled trial [O] . John F Forbes, Ivana Sestak, Anthony Howell, -1

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲随机对照试验
5. Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): A double-blind, randomised controlled trial [O] . Forbes, John F., Sestak, Ivana, Holcombe, Chris, 2016

机译：阿那曲唑与他莫昔芬预防局部绝经后原位导管癌的绝经后妇女局部和对侧乳腺癌的预防（IBIS-II DCIS）：一项双盲，随机对照试验

DCIS II trial: a randomised trial testing observation (no radiotherapy) against radiotherapy in women with low-risk completely excised oestrogen receptor (ER) positive ductal carcinoma in situ (DCIS) of the breast on adjuvant endocrine therapy.

著录项

引文网络

相似文献

相关主题

期刊订阅